A literature review and meta-analysis of drug company-funded mental health websites
- 10 May 2013
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 128 (6), 422-433
- https://doi.org/10.1111/acps.12146
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Childhood Adversities Increase the Risk of Psychosis: A Meta-analysis of Patient-Control, Prospective- and Cross-sectional Cohort StudiesSchizophrenia Bulletin, 2012
- Clinical and genetic outcome determinants of Internet‐ and group‐based cognitive behavior therapy for social anxiety disorderActa Psychiatrica Scandinavica, 2012
- Negative childhood experiences and mental health: theoretical, clinical and primary prevention implicationsThe British Journal of Psychiatry, 2012
- HON Label and DISCERN as Content Quality Indicators of Health-Related WebsitesPsychiatric Quarterly, 2011
- Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?Patient Education and Counseling, 2010
- The pharmaceutical industry and the internet: Are drug company funded depression websites biased?Journal of Mental Health, 2009
- Schizophrenia, drug companies and the internetSocial Science & Medicine, 2008
- Quality of Internet information referring to mental health and mental disorders in JapanPsychiatry and Clinical Neurosciences, 2007
- Internet information-seeking in mental healthThe British Journal of Psychiatry, 2006
- Direct-to-consumer advertising of psychotropicsThe British Journal of Psychiatry, 2004